No abstract available
Keywords: Adverse events; Antibody response; BNT162b2 vaccine; Delayed second vaccine dose; Neutralizing antibody; RBD-binding IgG antibody; SARS-CoV-2 infection; mRNA vaccine.
All Keywords
【저자키워드】 neutralizing antibody, BNT162b2 vaccine, SARS-COV-2 infection, Antibody Response, mRNA vaccine., adverse events, RBD-binding IgG antibody, Delayed second vaccine dose, 【초록키워드】 SARS-CoV-2, Vaccine, mRNA vaccine, BNT162b2, Adverse, Abstract, Delayed, RBD-binding IgG, 【제목키워드】 BNT162b2 mRNA vaccine, first dose, individual, infected with SARS-CoV-2,
【저자키워드】 neutralizing antibody, BNT162b2 vaccine, SARS-COV-2 infection, Antibody Response, mRNA vaccine., adverse events, RBD-binding IgG antibody, Delayed second vaccine dose, 【초록키워드】 SARS-CoV-2, Vaccine, mRNA vaccine, BNT162b2, Adverse, Abstract, Delayed, RBD-binding IgG, 【제목키워드】 BNT162b2 mRNA vaccine, first dose, individual, infected with SARS-CoV-2,
사용 가능한 초록 없음
{{ 키워드: }} 이상반응; 항체 반응; BNT162b2 백신; 지연된 두 번째 백신 접종; 중화항체; RBD-결합 IgG 항체; SARS-CoV-2 감염; mRNA 백신.